Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2J2 | P51589 | 8/20 | 0.67 |
| ▸ | NPY2R | P49146 | 1/20 | 0.49 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.48 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.48 |
| ▸ | HRH1 | P35367 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9873597 | 0.97 | CYP2J2 (0.63) | CYP2J2NPY2RPAX8KCNH2HRH1 | |
| SCHEMBL9874107 | 0.96 | CYP2J2 (0.62) | CYP2J2NPY2RPAX8KCNH2HRH1 | |
| SCHEMBL9874469 | 0.87 | CYP2J2 (0.65) | CYP2J2KCNH2HRH1CYP3A4CYP2C9 | |
| SCHEMBL9873141 | 0.86 | CYP2J2 (0.54) | CYP2J2KCNH2HRH1CYP3A4CYP2C9 | |
| SCHEMBL9874468 | 0.86 | CYP2J2 (0.54) | CYP2J2KCNH2CYP3A4CYP2C9CYP2B6 | |
| SCHEMBL9873117 | 0.86 | CYP2J2 (0.67) | CYP2J2KCNH2HRH1CYP3A4CYP2C9 | |
| SCHEMBL9872734 | 0.84 | CYP2J2 (0.67) | CYP2J2NPY2RPAX8KCNH2HRH1 | |
| SCHEMBL9873383 | 0.84 | CYP2J2 (0.61) | CYP2J2KCNH2HRH1CYP3A4CYP2C9 | |
| SCHEMBL9874544 | 0.83 | CYP2J2 (0.51) | CYP2J2KCNH2HRH1CYP3A4CYP2C9 | |
| SCHEMBL9871725 | 0.83 | CYP2J2 (0.60) | CYP2J2KCNH2HRH1CYP3A4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5057524-A | Asthma, dermatitis | A. H. ROBINS COMPANY INCORPORATED (US) | 1991-10-15 | — | — | US | disclosed |